Table 1 Epidemiological and clinical findings
From: Idiopathic intracranial hypertension in pediatric and adolescent patients
Total | Group I | Group II | P value | |
|---|---|---|---|---|
Age (in years) | 9.7 ± 4.4 (4–15) | 5.56 ± 1.9 (4–9) | 13.5 ± 1.3 (12–15) | < 0.001 |
Gender (F/M) | 16/19 (84.2%) | 6 /9 (66.7%) | 10/10 (100%) | 0.04 |
Follow-up (in months) | 12 ± 8.6 (4–36) | 12.1 ± 10.6(6–36) | 11.8 ± 6.7(4–24) | 0.9 |
Recurrence | 4/19 (21%) | 1/9 (11.1%) | 3/10 (30%) | 0.3 |
Clinical findings | ||||
Sixth nerve palsy | 4/19 (21%) | 4/9 (44.4%) | 0/10 (0%) | 0.018 |
Headache | 12/19 (63.2%) | 4/9 (44.4%) | 8/10 (80%) | 0.03 |
Blurring of vision | 8/19 (42.1%) | 3/9 (33.3%) | 5/10 (50%) | 0.4 |
Visual obscurations | 5/19 (26.3%) | 1/9 (11.1%) | 4/10 (40%) | 0.16 |
Deterioration of the school performance | 12/19 (63.16%) | 4/9 (44.4%) | 8/10 (80%) | 0.1 |
Irritability and irregular sleep | 8/19 (42.1%) | 5/9 (55.5%) | 3/10 (30%) | 0.27 |
ICP (mmH2O) | 291 ± 79.5 (180–460) | 258 ± 69 (180–350) | 320 ± 80 (250–460) | 0.09 |